CTS™ PSC Cryomedium

CTS™ PSC Cryomedium

CTS PSC Cryomedium:

• Provides efficient recovery and higher viability than traditional methods of PSC cryopreservation

• Facilitates regulatory filings through cGMP manufacturing and the availability of documentation

• Simplifies the transition from bench to clinic through the direct replacement of RUO PSC Cryopreservation Medium

Efficient recovery:

CTS PSC Cryomedium routinely achieves higher viability than traditional methods of cryopreservation and is compatible with clump and single cell passaged PSCs cultured in a variety of media systems. CTS PSC Cryomedium is provided as a ready-to-use, complete solution containing 10% DMSO for efficient cell addition. Separate additions of enhancing reagents are not required, helping save valuable preparation time.

Facilitates regulatory filings:

CTS PSC Cryomedium is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS PSC Cryomedium.

Simplifies transition from bench to clinic:

With its extensive safety testing, including adventitious agents, CTS PSC Cryomedium enables a smooth transition from RUO PSC Cryopreservation Medium.